• Aurora A Overexpression in High-Risk Retinoblastoma

  2026-08-13

  A 2024 study identifies Aurora kinase A (AURKA) overexpression as a recurrent feature of human retinoblastoma and links it to histopathologic factors associated with aggressive disease. By combining patient-tissue analysis with genetic depletion, pharmacologic inhibition, patient-derived models, and xenografts, the work supports AURKA as a mechanistically relevant target for retinoblastoma research.

• Imatinib (STI571) as a PDGFR Research Comparator

  2026-08-13

  Imatinib (STI571) can serve as a mechanistic comparator for PDGFR-driven signaling, proliferation, and vascular remodeling studies. This article connects kinase-level measurements with cell and tissue phenotypes while defining how to interpret imatinib alongside more selective PDGFR inhibitors.

• 2,2,2-Trichloroethanol: From Gel Readout to PD Assays

  2026-08-12

  2,2,2-Trichloroethanol is a small molecule biochemical that adds a sensitive protein-level readout to molecular biology research. This article explains how gel-based protein assessment can complement, but not replace, DAT neuroimaging when evaluating dopaminergic cell therapy models.

• Ezh2–p53 Control of Neat1 and Inflammasomes

  2026-08-12

  The reference study identifies a noncanonical, methyltransferase-independent role for Ezh2 in inflammasome activation. Ezh2 preserves H3K27 acetylation at the Neat1 promoter, while p53 recruits SIRT1 to oppose Neat1 transcription, establishing a chromatin-based competition model with implications for interpreting EZH2-targeted experiments.

• Fluconazole: A Benchmark for Resistance Models

  2026-08-11

  Fluconazole is more than a routine antifungal control: it is a mechanistic probe for ergosterol disruption, strain-specific susceptibility, and antifungal drug resistance research. This article translates comparative C. auris evidence into practical assay and model-selection decisions.

• Bestatin-Derived Inhibitors of IRAP and ERAP1

  2026-08-11

  The reference study develops α-hydroxy-β-amino acid derivatives of bestatin as selective inhibitors of oxytocinase-family M1 aminopeptidases. By combining stereoselective synthesis, enzyme assays, cellular evaluation, and X-ray crystallography, the authors identify a low-nanomolar IRAP inhibitor and show that GAMEN-loop interactions can strongly influence potency and selectivity.

• Carbapenemase Gene Transmission in CREC

  2026-08-10

  A 2025 BMC Microbiology study characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, China. Its combination of plasmid localization, conjugation, antimicrobial susceptibility testing, mobile-element analysis, and ERIC-PCR showed that blaNDM-1 was prevalent and readily transferable, while clonal and plasmid-associated dissemination both contributed to transmission risk.

• 5-Azacytidine: From Methylation to Viral Mimicry

  2026-08-09

  5-Azacytidine is more than a DNA demethylation agent: in the right epigenetic context, it can help expose endogenous viral signals to the immune system. This article translates recent PTEN-deficient glioblastoma findings into practical assay design, controls, and interpretation strategies.

• AG-126: ERK Signaling in Translational Neuroscience

  2026-08-08

  AG-126, also known as Tyrphostin AG-126, provides a pharmacological lens for studying ERK1/2 signaling in inflammatory and neurobiological systems. This thought-leadership article connects product-level evidence with findings that link Neuroligin 1 loss, D2-MSN hyperactivation, PKC overactivation, and repetitive behavior, while defining the limits of translating inflammatory-model data into circuit neuroscience.

• 3-Methyladenine for Autophagy Assays

  2026-08-07

  Use 3-Methyladenine as a time-sensitive class III PI3K perturbation to test whether autophagy initiation contributes to cardiac injury, cancer-cell survival, or migration phenotypes. This workflow emphasizes matched vehicle controls, flux-aware readouts, and careful interpretation of its persistent class I PI3K effects.

• Genetic Engineering Enhances Immunotherapy in Immune-Cold Tu

  2026-08-07

  He et al. (2025) present a tumor-targeted genetic engineering approach that orchestrates T cell immunity in 'immune-cold' solid tumors. Their dual-function plasmid vector significantly improves T cell infiltration and synergizes with established immunotherapies, holding promise for translational applications in solid tumor treatment.

• Anlotinib Hydrochloride: Shaping Translational Anti-Angiogen

  2026-08-06

  Explore how Anlotinib hydrochloride, a novel multi-target tyrosine kinase inhibitor, enables translational researchers to overcome hurdles in anti-angiogenic cancer research. This thought-leadership article integrates mechanistic insights, experimental best practices, and fresh clinical evidence—highlighting how APExBIO's Anlotinib hydrochloride advances the field beyond conventional tools.

• Sodium Ascorbate in Cancer Cell Assays: Reliable Solutions f

  2026-08-06

  This article provides scenario-driven guidance for biomedical researchers and lab technicians on using Sodium Ascorbate (SKU B1834) in cell viability, proliferation, and cytotoxicity workflows. With evidence-backed insights and practical Q&A, it demonstrates how APExBIO's Sodium Ascorbate ensures reproducibility and high performance in cancer research, especially for glioblastoma models.

• FTSJ3 Loss Drives R-Loop DNA Damage and Chemosensitivity in

  2026-08-05

  The referenced study uncovers FTSJ3 as a key regulator of R-loop homeostasis and genomic stability in lung cancer cells. Loss of FTSJ3 leads to excessive R-loop formation, increased DNA damage, and enhanced sensitivity to cisplatin, highlighting FTSJ3 as both a therapeutic target and a potential biomarker for chemotherapy responsiveness.

• Localized Muscle-Derived BDNF Regulates Early Neuromuscular

  2026-08-05

  This study uncovers the spatially restricted release of muscle-generated BDNF as a critical regulator in the initial formation of postsynaptic acetylcholine receptor (AChR) clusters at neuromuscular junctions (NMJs). By detailing the calcium-dependent mechanisms of BDNF trafficking and proteolytic processing, the research provides new insights into synapse assembly and potential experimental approaches for dissecting calcium signaling in synaptic development.

15614 records 1/1041 page Next 12345 下5页 Last page